Track CTOR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CTOR - Citius Oncology, Inc. (CTOR) has a earnings per share of -$0.27, down 145.5% over the past year.
Latest EPS (Actual)
-$0.27
Beat Rate
14.3%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.01 | -$0.27 | Miss | -2600.00% |
| Feb 2026 | -$0.02 | -$0.06 | Miss | -200.00% |
| Dec 2025 | -$0.06 | -$0.06 | Meet | +0.00% |
| Aug 2025 | -$0.15 | -$0.08 | Beat | +46.67% |
| May 2025 | -$0.09 | -$0.11 | Miss | -22.22% |
| Feb 2025 | -$0.06 | -$0.09 | Miss | -55.17% |
| Dec 2024 | -$0.08 | -$0.31 | Miss | -282.38% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.